Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Wendy Armstrong

Concepts (357)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
63
2024
2730
6.100
Why?
Epidemics
6
2024
82
2.170
Why?
Communicable Diseases
8
2023
152
1.970
Why?
Anti-Retroviral Agents
5
2019
231
1.760
Why?
Anti-HIV Agents
13
2024
757
1.630
Why?
Viral Load
13
2023
449
1.210
Why?
Infectious Disease Medicine
2
2017
12
1.120
Why?
Continuity of Patient Care
5
2022
277
1.040
Why?
Internal Medicine
3
2016
247
0.950
Why?
Social Stigma
2
2024
117
0.940
Why?
AIDS-Related Opportunistic Infections
5
2019
123
0.940
Why?
HIV
13
2023
227
0.940
Why?
Drug Monitoring
2
2016
215
0.800
Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
18
0.790
Why?
Internship and Residency
6
2021
1052
0.780
Why?
Pre-Exposure Prophylaxis
3
2024
205
0.740
Why?
Adenine
2
2020
257
0.680
Why?
Antiretroviral Therapy, Highly Active
6
2019
267
0.670
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
17
0.670
Why?
Diagnostic Tests, Routine
2
2021
104
0.640
Why?
Acquired Immunodeficiency Syndrome
7
2022
228
0.630
Why?
Humans
91
2024
129687
0.620
Why?
Consumer Advocacy
1
2018
12
0.600
Why?
Health Services Accessibility
4
2024
903
0.590
Why?
Career Choice
3
2018
206
0.590
Why?
Lost to Follow-Up
2
2017
21
0.580
Why?
United States
25
2024
13906
0.580
Why?
Health Policy
3
2023
354
0.550
Why?
Delivery of Health Care
4
2021
900
0.550
Why?
Substance-Related Disorders
6
2021
1022
0.520
Why?
CD4 Lymphocyte Count
6
2020
267
0.520
Why?
Georgia
10
2024
80
0.500
Why?
Antimicrobial Stewardship
3
2023
107
0.480
Why?
Medication Adherence
2
2017
561
0.480
Why?
Disease Management
1
2019
588
0.480
Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
12
0.460
Why?
Biomedical Research
2
2018
640
0.450
Why?
Urban Population
1
2017
443
0.440
Why?
Bone Diseases
1
2014
57
0.440
Why?
Financing, Government
1
2014
43
0.430
Why?
HIV-1
5
2016
838
0.430
Why?
Patient Acceptance of Health Care
2
2017
763
0.430
Why?
Metabolic Diseases
1
2014
104
0.420
Why?
Rural Population
1
2017
521
0.410
Why?
Drug Resistance, Viral
2
2005
110
0.410
Why?
Ventriculostomy
1
2012
21
0.380
Why?
Chronic Pain
3
2021
253
0.380
Why?
Ambulatory Care
2
2021
506
0.380
Why?
Medication Errors
1
2012
96
0.370
Why?
Mycoses
1
2012
73
0.370
Why?
Critical Care
1
2016
551
0.360
Why?
Central Nervous System Diseases
1
2012
69
0.360
Why?
Prostheses and Implants
1
2012
135
0.350
Why?
Disease Transmission, Infectious
1
2011
55
0.340
Why?
Gram-Positive Bacterial Infections
2
2008
64
0.340
Why?
Analgesics, Opioid
5
2021
913
0.340
Why?
Cellulitis
2
2011
49
0.330
Why?
Bacterial Infections
1
2012
233
0.330
Why?
Microbiology
3
2014
24
0.330
Why?
Physicians
5
2019
871
0.330
Why?
Global Health
2
2018
328
0.310
Why?
Dermatitis
1
2008
19
0.310
Why?
Male
39
2024
63691
0.310
Why?
Female
40
2024
68751
0.310
Why?
Medical Informatics
1
2009
99
0.300
Why?
Patient-Centered Care
1
2014
508
0.300
Why?
Adult
32
2024
35607
0.300
Why?
Education, Medical, Graduate
5
2023
441
0.300
Why?
Gram-Negative Bacterial Infections
1
2008
45
0.300
Why?
Middle Aged
31
2024
31165
0.290
Why?
Information Dissemination
1
2009
206
0.280
Why?
Africa, Eastern
2
2017
12
0.280
Why?
AIDS Vaccines
2
2005
47
0.280
Why?
Periodicals as Topic
1
2009
204
0.270
Why?
Internet
2
2014
619
0.260
Why?
Developing Countries
3
2017
284
0.260
Why?
Pneumonia, Pneumocystis
4
2015
36
0.260
Why?
Curriculum
5
2023
925
0.260
Why?
Mycobacterium chelonae
1
2005
8
0.250
Why?
Databases, Factual
2
2019
1269
0.250
Why?
Rilpivirine
1
2024
7
0.230
Why?
Fellowships and Scholarships
4
2023
276
0.220
Why?
Skin
1
2008
725
0.220
Why?
Interviews as Topic
2
2017
709
0.210
Why?
Cost-Benefit Analysis
3
2021
569
0.210
Why?
Meningoencephalitis
1
2003
25
0.210
Why?
West Nile virus
1
2003
40
0.210
Why?
Pyridones
1
2024
158
0.200
Why?
Practice Guidelines as Topic
3
2019
1506
0.200
Why?
Pain Management
3
2021
326
0.200
Why?
Bacteria
1
2008
814
0.190
Why?
Simulation Training
1
2023
82
0.190
Why?
Anti-Infective Agents
3
2015
248
0.190
Why?
Coronary Artery Bypass
1
2003
224
0.190
Why?
Erythrocyte Transfusion
1
2003
181
0.180
Why?
Mass Screening
2
2020
1192
0.180
Why?
Colony-Stimulating Factors
1
2001
35
0.180
Why?
Obesity
1
2014
2885
0.180
Why?
Registries
2
2019
1896
0.180
Why?
Contact Tracing
1
2020
24
0.180
Why?
Sexual and Gender Minorities
1
2024
196
0.170
Why?
Prescription Drug Misuse
1
2021
39
0.170
Why?
Mycobacterium Infections, Nontuberculous
1
2005
353
0.170
Why?
Cities
4
2022
105
0.170
Why?
Erythropoietin
1
2001
88
0.170
Why?
Models, Theoretical
2
2021
549
0.170
Why?
Life Expectancy
1
2020
61
0.160
Why?
Health Equity
1
2021
87
0.160
Why?
Policy
1
2021
143
0.160
Why?
Cross-Sectional Studies
5
2021
5083
0.160
Why?
Interleukin-2
1
2001
437
0.160
Why?
Alanine
1
2020
143
0.160
Why?
Fever of Unknown Origin
1
1999
10
0.160
Why?
Heart Diseases
1
2022
352
0.150
Why?
Mentors
2
2018
177
0.150
Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
37
0.150
Why?
Prevalence
5
2024
2563
0.150
Why?
Comorbidity
2
2020
1551
0.150
Why?
Tenofovir
1
2020
232
0.150
Why?
Pandemics
3
2021
1496
0.150
Why?
Microbial Sensitivity Tests
3
2016
349
0.150
Why?
Hospitalization
4
2020
2075
0.140
Why?
Cohort Studies
6
2019
5434
0.140
Why?
Physician Assistants
1
2019
89
0.140
Why?
Anti-Bacterial Agents
4
2011
1708
0.140
Why?
Capital Financing
1
2017
7
0.140
Why?
Patient Identification Systems
1
2017
16
0.140
Why?
Sustained Virologic Response
1
2017
37
0.140
Why?
Africa
1
2017
99
0.140
Why?
Nurse Practitioners
1
2019
133
0.140
Why?
Research Personnel
1
2018
156
0.130
Why?
Viral Tropism
1
2016
29
0.130
Why?
Financing, Personal
1
2016
26
0.130
Why?
Opioid-Related Disorders
2
2021
483
0.130
Why?
Case Management
1
2016
64
0.130
Why?
Risk Factors
6
2019
9787
0.120
Why?
Hospitals
2
2021
646
0.120
Why?
Motivation
2
2017
548
0.120
Why?
Pneumonia, Viral
1
2020
341
0.120
Why?
Coronavirus Infections
1
2020
335
0.120
Why?
Drug Utilization Review
1
2015
57
0.120
Why?
Time-to-Treatment
1
2017
179
0.120
Why?
Organizational Policy
1
2015
79
0.120
Why?
HIV Protease Inhibitors
1
2015
68
0.120
Why?
Patient Navigation
1
2016
78
0.120
Why?
Esophageal Diseases
1
2015
27
0.120
Why?
Online Systems
1
2014
22
0.120
Why?
Candidiasis
1
2015
57
0.120
Why?
Pregnancy Complications, Infectious
1
2019
367
0.120
Why?
Cytosol
1
2015
219
0.110
Why?
Healthcare Disparities
1
2020
580
0.110
Why?
Alcoholism
1
2021
766
0.110
Why?
Organophosphates
1
2015
121
0.110
Why?
Ambulatory Care Facilities
1
2016
228
0.110
Why?
Drug Interactions
1
2015
397
0.110
Why?
Patient Readmission
1
2019
668
0.100
Why?
DNA, Viral
2
2012
347
0.100
Why?
Telemedicine
1
2021
792
0.100
Why?
Aged
8
2022
22101
0.100
Why?
Health Plan Implementation
1
2014
137
0.100
Why?
Dihydropteroate Synthase
2
2004
3
0.100
Why?
Pilot Projects
2
2017
1594
0.100
Why?
Incidence
2
2021
2644
0.100
Why?
Retrospective Studies
7
2022
14525
0.100
Why?
Medication Reconciliation
1
2012
29
0.100
Why?
Leukocytes, Mononuclear
1
2015
546
0.100
Why?
Myocardial Infarction
2
2019
1021
0.100
Why?
Longitudinal Studies
2
2019
2724
0.100
Why?
Oligopeptides
1
2014
260
0.100
Why?
HIV Antibodies
1
2012
57
0.100
Why?
Socioeconomic Factors
2
2020
1214
0.090
Why?
Primary Health Care
2
2019
1687
0.090
Why?
Mycobacterium haemophilum
1
2011
1
0.090
Why?
Electronic Health Records
1
2019
975
0.090
Why?
Catheter-Related Infections
1
2012
72
0.090
Why?
Parasitic Diseases
1
2011
8
0.090
Why?
Research
1
2014
420
0.090
Why?
Cytomegalovirus
1
2012
154
0.090
Why?
Pneumocystis
2
2001
11
0.090
Why?
Health Care Costs
1
2014
367
0.090
Why?
Mycobacterium Infections
1
2011
62
0.090
Why?
Simian Immunodeficiency Virus
1
2011
86
0.090
Why?
Surveys and Questionnaires
5
2023
5427
0.090
Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
84
0.090
Why?
Education, Medical, Undergraduate
1
2013
179
0.090
Why?
Pyridines
1
2014
478
0.090
Why?
Geography
1
2011
188
0.080
Why?
Sulfonamides
1
2014
497
0.080
Why?
Cytomegalovirus Infections
1
2012
189
0.080
Why?
Deep Brain Stimulation
1
2012
125
0.080
Why?
Rectum
1
2011
170
0.080
Why?
Antibodies, Neutralizing
1
2012
265
0.080
Why?
Desiccation
1
2009
20
0.080
Why?
Colon
1
2011
257
0.080
Why?
Emigrants and Immigrants
1
2011
122
0.080
Why?
Education, Medical, Continuing
1
2009
123
0.080
Why?
Drug Therapy, Combination
3
2014
1042
0.070
Why?
Syphilis, Cutaneous
1
2007
3
0.070
Why?
Immunoglobulin G
1
2012
851
0.070
Why?
Specimen Handling
1
2009
163
0.070
Why?
Dendritic Cells
1
2011
481
0.070
Why?
Adolescent
4
2021
20415
0.070
Why?
Plasma
1
2009
206
0.070
Why?
Hepacivirus
1
2009
242
0.070
Why?
Treatment Outcome
6
2024
10221
0.070
Why?
Risk Assessment
3
2019
3260
0.070
Why?
B-Lymphocytes
1
2012
816
0.070
Why?
Hepatitis C
1
2009
244
0.060
Why?
HIV-2
1
2005
18
0.060
Why?
CD4-Positive T-Lymphocytes
1
2011
1058
0.060
Why?
Diagnosis, Differential
2
2007
1433
0.060
Why?
Sex Factors
1
2011
1973
0.060
Why?
Dapsone
2
2004
7
0.060
Why?
Patient Education as Topic
1
2009
743
0.060
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
38
0.060
Why?
Pneumocystis carinii
1
2004
11
0.060
Why?
Chronic Disease
2
2012
1723
0.060
Why?
Virulence
1
2005
255
0.050
Why?
Mediastinitis
1
2003
3
0.050
Why?
Vancomycin Resistance
1
2003
14
0.050
Why?
Young Adult
2
2021
12457
0.050
Why?
Enterococcus faecium
1
2003
14
0.050
Why?
Delayed-Action Preparations
1
2024
174
0.050
Why?
Wound Healing
1
2005
308
0.050
Why?
Fatal Outcome
1
2003
299
0.050
Why?
Liver Failure
1
2002
91
0.050
Why?
Biopsy
1
2005
1087
0.050
Why?
Cryptococcosis
1
2001
26
0.050
Why?
Adipose Tissue
1
2005
594
0.050
Why?
Transplantation, Homologous
1
2002
402
0.050
Why?
Dental Care
1
2021
26
0.050
Why?
Mutation
2
2004
3705
0.050
Why?
Intracranial Hypertension
1
2001
37
0.050
Why?
Time Factors
3
2019
6545
0.050
Why?
Coronary Disease
2
2003
385
0.040
Why?
Naphthoquinones
1
2001
19
0.040
Why?
Blood
2
2012
105
0.040
Why?
Cytochrome b Group
1
2001
18
0.040
Why?
Quality-Adjusted Life Years
1
2021
106
0.040
Why?
Renal Insufficiency
1
2002
149
0.040
Why?
Patient Outcome Assessment
1
2021
127
0.040
Why?
Trust
1
2021
116
0.040
Why?
Meningitis
1
2001
79
0.040
Why?
Prospective Studies
1
2012
7145
0.040
Why?
Neutropenia
1
2001
137
0.040
Why?
Antifungal Agents
1
2001
130
0.040
Why?
Personal Satisfaction
1
2021
204
0.040
Why?
Anemia
1
2001
161
0.040
Why?
JC Virus
1
2019
23
0.040
Why?
Antiviral Agents
1
2005
718
0.040
Why?
Spinal Diseases
1
1999
47
0.040
Why?
Asymptomatic Infections
1
2019
26
0.040
Why?
Polyomavirus Infections
1
2019
27
0.040
Why?
Boston
1
2019
89
0.040
Why?
Esophageal Stenosis
1
1999
51
0.040
Why?
Polymerase Chain Reaction
3
2011
1033
0.040
Why?
Insurance, Health
1
2021
269
0.040
Why?
Abscess
1
1999
73
0.040
Why?
Health Status Disparities
1
2021
256
0.040
Why?
Training Support
1
2018
28
0.040
Why?
Benchmarking
1
2019
176
0.040
Why?
Preceptorship
1
2018
63
0.040
Why?
Substance Abuse Detection
1
2019
79
0.040
Why?
Multicenter Studies as Topic
1
2019
287
0.040
Why?
Recombinant Proteins
1
2001
1310
0.040
Why?
Heart-Assist Devices
1
2003
537
0.030
Why?
Patient Satisfaction
1
2021
636
0.030
Why?
Dyslipidemias
1
2019
177
0.030
Why?
Hospitals, Public
1
2017
26
0.030
Why?
Drug Administration Schedule
1
2019
766
0.030
Why?
Medicare
1
2022
719
0.030
Why?
Prenatal Care
1
2019
277
0.030
Why?
Odds Ratio
1
2019
1021
0.030
Why?
Needs Assessment
1
2018
357
0.030
Why?
Postpartum Period
1
2019
331
0.030
Why?
Public Health Surveillance
1
2016
68
0.030
Why?
Delayed Diagnosis
1
2016
79
0.030
Why?
Multivariate Analysis
1
2019
1500
0.030
Why?
Stents
1
1999
504
0.030
Why?
Guideline Adherence
1
2019
527
0.030
Why?
Motivational Interviewing
1
2016
101
0.030
Why?
Societies, Medical
1
2018
744
0.030
Why?
Neopterin
1
2014
12
0.030
Why?
Darunavir
1
2014
18
0.030
Why?
Atazanavir Sulfate
1
2014
41
0.030
Why?
Ritonavir
1
2014
73
0.030
Why?
Randomized Controlled Trials as Topic
1
2019
1368
0.030
Why?
Blood Proteins
1
2014
245
0.020
Why?
Transplantation
1
2012
31
0.020
Why?
Inpatients
1
2016
477
0.020
Why?
Smoking
1
2019
1502
0.020
Why?
Rifabutin
1
2011
6
0.020
Why?
Clarithromycin
1
2011
28
0.020
Why?
Ofloxacin
1
2011
24
0.020
Why?
Viremia
1
2012
131
0.020
Why?
Quality of Life
1
2023
2694
0.020
Why?
Receptors, Immunologic
1
2012
216
0.020
Why?
Macaca mulatta
1
2011
150
0.020
Why?
Integrins
1
2011
94
0.020
Why?
RNA, Viral
1
2014
620
0.020
Why?
Practice Patterns, Physicians'
1
2019
1271
0.020
Why?
Data Interpretation, Statistical
1
2012
338
0.020
Why?
Programmed Cell Death 1 Receptor
1
2012
232
0.020
Why?
Hypertension
1
2019
1242
0.020
Why?
Immunocompromised Host
1
2011
199
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
756
0.020
Why?
Health Promotion
1
2015
718
0.020
Why?
Blotting, Western
1
2011
1204
0.020
Why?
Neoplasms
1
2002
2454
0.020
Why?
Feces
1
2011
442
0.020
Why?
Protein Binding
1
2014
2122
0.020
Why?
False Negative Reactions
1
2007
53
0.020
Why?
Flow Cytometry
1
2011
1160
0.020
Why?
Lymphocyte Activation
1
2011
1110
0.020
Why?
Cardiovascular Diseases
1
2019
2008
0.020
Why?
Pregnancy
1
2019
6412
0.020
Why?
Gene Expression Profiling
1
2011
1686
0.010
Why?
Genotype
1
2009
1829
0.010
Why?
T-Lymphocytes
1
2012
1937
0.010
Why?
Chemoprevention
1
2004
91
0.010
Why?
China
1
2004
192
0.010
Why?
Infant
1
2016
8987
0.010
Why?
Child, Preschool
1
2016
10487
0.010
Why?
Atovaquone
1
2001
3
0.010
Why?
Reproducibility of Results
1
2009
3084
0.010
Why?
Survival
1
2001
38
0.010
Why?
Ubiquinone
1
2001
28
0.010
Why?
Gene Amplification
1
2001
103
0.010
Why?
Cardiomyopathy, Dilated
1
2003
381
0.010
Why?
Postoperative Complications
2
2003
2470
0.010
Why?
Biomarkers
1
2011
3969
0.010
Why?
Sulfones
1
2000
108
0.010
Why?
Epidural Space
1
1999
10
0.010
Why?
Animals
2
2011
35404
0.010
Why?
Radiotherapy, Adjuvant
1
1999
208
0.010
Why?
Recurrence
1
2001
1012
0.010
Why?
Radiation Injuries
1
1999
135
0.010
Why?
Polymorphism, Genetic
1
2001
636
0.010
Why?
Heart Transplantation
1
2003
722
0.010
Why?
Esophagus
1
1999
248
0.010
Why?
Child
1
2016
20882
0.010
Why?
Molecular Sequence Data
1
2001
2833
0.010
Why?
Esophageal Neoplasms
1
1999
297
0.010
Why?
Follow-Up Studies
1
2003
4892
0.010
Why?
Carcinoma, Squamous Cell
1
1999
627
0.010
Why?
Case-Control Studies
1
2001
3381
0.010
Why?
Angina Pectoris
1
1971
67
0.010
Why?
Tomography, X-Ray Computed
1
1999
2510
0.010
Why?
Coronary Vessels
1
1971
239
0.000
Why?
Aorta
1
1971
408
0.000
Why?
Magnetic Resonance Imaging
1
1999
3394
0.000
Why?
Angiocardiography
1
1971
1
0.000
Why?
Extracorporeal Circulation
1
1971
13
0.000
Why?
Methods
1
1971
64
0.000
Why?
Saphenous Vein
1
1971
32
0.000
Why?
Transplantation, Autologous
1
1971
213
0.000
Why?
Emergencies
1
1971
156
0.000
Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)